ARCHIVES

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

This article is from The Cancer Letter archive.

Vol. 31 No. 20 | May 20, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Push “Cancer Prevention Awareness” This Month; Three RFPs Delayed For Changes

February 17, 1984

Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development.

March 10, 2000

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

FDA Recruiting ODAC Consumer Rep Candidates

March 31, 1995

Clinical Trials Approved By NCI CTEP During July

August 30, 2002

Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds

July 30, 2010